Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$8.72 - $11.56 $113 - $150
-13 Reduced 68.42%
6 $0
Q1 2022

Apr 29, 2022

SELL
$9.81 - $15.4 $133,337 - $209,316
-13,592 Reduced 99.86%
19 $0
Q4 2021

Feb 02, 2022

BUY
$12.09 - $14.68 $7,955 - $9,659
658 Added 5.08%
13,611 $184,000
Q3 2021

Nov 02, 2021

BUY
$13.25 - $15.13 $8,082 - $9,229
610 Added 4.94%
12,953 $176,000
Q2 2021

Jul 30, 2021

BUY
$12.97 - $16.15 $181 - $226
14 Added 0.11%
12,343 $176,000
Q1 2021

May 06, 2021

BUY
$13.59 - $18.54 $167,551 - $228,579
12,329 New
12,329 $172,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Clearview Wealth Advisors LLC Portfolio

Follow Clearview Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearview Wealth Advisors LLC with notifications on news.